1-5 of 5
Authors: John Mellors
Journal Article
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
The Journal of Infectious Diseases, Volume 226, Issue 12, 15 December 2022, Pages 2170–2180, https://doi.org/10.1093/infdis/jiac415
Published: 14 October 2022
Journal Article
Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084
The Journal of Infectious Diseases, Volume 225, Issue 10, 15 May 2022, Pages 1741–1749, https://doi.org/10.1093/infdis/jiab576
Published: 18 March 2022
Journal Article
Contribution of Coronavirus-Specific Immunoglobulin G Responses to Complement Overactivation in Patients with Severe Coronavirus Disease 2019
The Journal of Infectious Diseases, Volume 226, Issue 5, 1 September 2022, Pages 766–777, https://doi.org/10.1093/infdis/jiac091
Published: 10 March 2022
Journal Article
Residual Human Immunodeficiency Virus (HIV) Type 1 RNA and DNA in Lymph Nodes and HIV RNA in Genital Secretions and in Cerebrospinal Fluid after Suppression of Viremia for 2 Years Get access
The Journal of Infectious Diseases, Volume 183, Issue 9, 1 May 2001, Pages 1318–1327, https://doi.org/10.1086/319864
Published: 01 May 2001
Journal Article
A Randomized, Controlled Trial of Indinavir, Zidovudine, and Lamivudine in Adults with Advanced Human Immunodeficiency Virus Type 1 Infection and Prior Antiretroviral Therapy Get access
The Journal of Infectious Diseases, Volume 180, Issue 3, September 1999, Pages 659–665, https://doi.org/10.1086/314948
Published: 01 September 1999
